{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-006448","form_type":"8-K","ticker":null,"cik":"0001697884","company_name":"VITASPRING BIOMEDICAL CO. LTD.","filed_at":"2025-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.700264+00:00","generated_at":"2026-05-17T10:15:30.888091+00:00","sec_items":["4.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"VitaSpring Biomedical appoints JP Centurion as new independent auditor","bullets":["Engaged JP Centurion & Partners PLT as independent registered public accounting firm effective August 19, 2025.","No consultations with JP Centurion on accounting principles or audit opinion prior to engagement.","No disagreements or reportable events occurred with former auditor (resignation disclosed in prior 8-K on Aug 7, 2025).","New auditor will audit consolidated financial statements and perform review procedures for periodic reports."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-006448","json":"https://secwatch.observer/filing/0001683168-25-006448.json","markdown":"https://secwatch.observer/filing/0001683168-25-006448.md","text":"https://secwatch.observer/filing/0001683168-25-006448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1697884/000168316825006448/0001683168-25-006448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1697884/000168316825006448/vitaspring_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:15:30.888091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"72e62a926e22f46e6b56e9e08c464e3f505b4b04","claim":"VITASPRING BIOMEDICAL CO. LTD. engaged JP Centurion & Partners PLT as its auditor.","evidence_excerpt":"On August 19, 2025, the Board of Directors of VitaSpring Biomedical Co., Ltd. (the “Company”) approved the engagement of JP Centurion & Partners PLT (“JP Centurion”) as the Company’s independent registered public accounting firm, effective as of such date.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1697884/000168316825006448/0001683168-25-006448-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"JP Centurion & Partners PLT"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}